Literature DB >> 2621160

Leinamycin, a new antitumor antibiotic from Streptomyces: producing organism, fermentation and isolation.

M Hara1, K Asano, I Kawamoto, T Takiguchi, S Katsumata, K Takahashi, H Nakano.   

Abstract

Leinamycin (DC 107) is newly discovered antitumor antibiotic with an unusual 1,3-dioxo-1,2-dithiolane structure. Five different producing strains were isolated from soils collected in Japan during 1985-1988 and were taxonomically assigned as Streptomyces. Fermentation studies indicate: Leinamycin was unstable in culture broth. A chemically defined medium could be designed for a preferable production. Streptomyces sp. S-140 grew on medium supplemented with Zn2+ and high porus polymer resin and accumulated 32 micrograms/ml of leinamycin. Improved isolation methods are described along with identification of mikamycin A co-produced with leinamycin by the strain S-140.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2621160     DOI: 10.7164/antibiotics.42.1768

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  45 in total

1.  DNA cleavage induced by antitumor antibiotic leinamycin and its biological consequences.

Authors:  Velliyur Viswesh; Allison M Hays; Kent Gates; Daekyu Sun
Journal:  Bioorg Med Chem       Date:  2012-05-23       Impact factor: 3.641

2.  Noncovalent DNA binding drives DNA alkylation by leinamycin: evidence that the Z,E-5-(thiazol-4-yl)-penta-2,4-dienone moiety of the natural product serves as an atypical DNA intercalator.

Authors:  Mostafa I Fekry; Jozsef Szekely; Sanjay Dutta; Leonid Breydo; Hong Zang; Kent S Gates
Journal:  J Am Chem Soc       Date:  2011-10-18       Impact factor: 15.419

3.  Apratoxin H and apratoxin A sulfoxide from the Red Sea cyanobacterium Moorea producens.

Authors:  Christopher C Thornburg; Elise S Cowley; Justyna Sikorska; Lamiaa A Shaala; Jane E Ishmael; Diaa T A Youssef; Kerry L McPhail
Journal:  J Nat Prod       Date:  2013-09-09       Impact factor: 4.050

4.  Fermentative production of self-toxic fungal secondary metabolites.

Authors:  Maya P Singh; Margaret M Leighton; Laurel R Barbieri; Deborah M Roll; Susan E Urbance; Linda Hoshan; Leonard A McDonald
Journal:  J Ind Microbiol Biotechnol       Date:  2009-12-24       Impact factor: 3.346

5.  Less than the sum of its parts, a leinamycin precursor has superior properties.

Authors:  William P Katt; Richard A Cerione
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-23       Impact factor: 11.205

Review 6.  Oxidative Cyclization in Natural Product Biosynthesis.

Authors:  Man-Cheng Tang; Yi Zou; Kenji Watanabe; Christopher T Walsh; Yi Tang
Journal:  Chem Rev       Date:  2016-12-12       Impact factor: 60.622

7.  Entering the leinamycin rearrangement via 2-(trimethylsilyl)ethyl sulfoxides.

Authors:  Kripa Keerthi; Kent S Gates
Journal:  Org Biomol Chem       Date:  2007-04-13       Impact factor: 3.876

8.  Structure of the bifunctional acyltransferase/decarboxylase LnmK from the leinamycin biosynthetic pathway revealing novel activity for a double-hot-dog fold.

Authors:  Jeremy R Lohman; Craig A Bingman; George N Phillips; Ben Shen
Journal:  Biochemistry       Date:  2013-01-24       Impact factor: 3.162

9.  P450-Catalyzed Tailoring Steps in Leinamycin Biosynthesis Featuring Regio- and Stereoselective Hydroxylations and Substrate Promiscuities.

Authors:  Thomas Kwong; Ming Ma; Guohui Pan; Dong Yang; Chunying Yang; Jeremy R Lohman; Jeffrey D Rudolf; John L Cleveland; Ben Shen
Journal:  Biochemistry       Date:  2018-08-02       Impact factor: 3.162

10.  Characterization of DNA damage induced by a natural product antitumor antibiotic leinamycin in human cancer cells.

Authors:  Velliyur Viswesh; Kent Gates; Daekyu Sun
Journal:  Chem Res Toxicol       Date:  2010-01       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.